Hypopituitarism Following Traumatic Brain Injury or Spontaneous Subarachnoidal Haemorrhages

This study has been completed.

Sponsor:

Collaborators:

University of Copenhagen

Novo Nordisk

AP Moeller Foundation

Information provided by:

Rigshospitalet, Denmark

ClinicalTrials.gov Identifier:

NCT00435006

First received: February 13, 2007

Last updated: NA

Last verified: February 2007

History: No changes posted

Tracking Information

First Received Date ^ICMJE

February 13, 2007

Last Updated Date

February 13, 2007

Start Date ^ICMJE

August 2003

Primary Completion Date

Not Provided

Current Primary Outcome Measures ^ICMJE

Not Provided

Original Primary Outcome Measures ^ICMJE

Not Provided

Change History

No Changes Posted

Current Secondary Outcome Measures ^ICMJE

Not Provided

Original Secondary Outcome Measures ^ICMJE

Not Provided

Current Other Outcome Measures ^ICMJE

Not Provided

Original Other Outcome Measures ^ICMJE

Not Provided

Descriptive Information

Brief Title ^ICMJE

Hypopituitarism Following Traumatic Brain Injury or Spontaneous Subarachnoidal Haemorrhages

Official Title ^ICMJE

Not Provided

Brief Summary

The purpose of this study is to assess the prevalence and predictors of pituitary dysfunction, as well as secondary out-come in patients with traumatic brain injury or spontaneous subarachnoidal haemorrhages.

Detailed Description

Not Provided

Study Type ^ICMJE

Observational

Study Design ^ICMJE

Observational Model: Defined Population
Time Perspective: Longitudinal
Time Perspective: Retrospective/Prospective

Target Follow-Up Duration

Not Provided

Biospecimen

Not Provided

Sampling Method

Not Provided

Study Population

Not Provided

Condition ^ICMJE

Brain Injuries
Intracranial Aneurysm

Intervention ^ICMJE

Not Provided

Study Group/Cohort (s)

Not Provided

Publications *

Not Provided

* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.

Recruitment Information

Recruitment Status ^ICMJE

Completed

Enrollment ^ICMJE

Not Provided

Completion Date

June 2006

Primary Completion Date

Not Provided

Eligibility Criteria ^ICMJE

Inclusion Criteria:

Clinical diagnosis of traumatic brain injury (TBI) or subarachnoidal haemorrhages (SAH)

Exclusion Criteria:

Alcohol or drug abuse
Prior TBI or SAH
Chronic use of glucocorticoids
Pregnancy or breast feeding
Diagnosis of psychiatric diseases or malignant neoplasms

Gender

Both

Ages

18 Years to 65 Years

Accepts Healthy Volunteers

Not Provided

Contacts ^ICMJE

Contact information is only displayed when the study is recruiting subjects

Location Countries ^ICMJE

Denmark

Administrative Information

NCT Number ^ICMJE

NCT00435006

Other Study ID Numbers ^ICMJE

KF-01-107/03

Has Data Monitoring Committee

Not Provided

Responsible Party

Not Provided

Study Sponsor ^ICMJE

Rigshospitalet, Denmark

Collaborators ^ICMJE

University of Copenhagen
Novo Nordisk
AP Moeller Foundation

Investigators ^ICMJE

Principal Investigator:

Marianne C Klose, MD

Dept. of Endocrinology PE2131, Copenhagen University Hospital, Rigshospitalet

Information Provided By

Rigshospitalet, Denmark

Verification Date

February 2007

^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP

To Top